Helping young cancer survivors build resilience
Promoting Resilience in Early Survivorship among Adolescents and Young Adults with Cancer
This study is all about helping young people aged 12-25 who have finished cancer treatment by using a program called PRISM, which offers online coaching and a cool app to teach them how to manage stress and set goals, so they can feel stronger and enjoy life more as they move into survivorship.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11076803 on NIH RePORTER |
What this research studies
This research focuses on supporting adolescents and young adults (ages 12-25) who are transitioning from cancer treatment to survivorship. It utilizes a program called PRISM, which includes telehealth sessions with certified coaches and an award-winning smartphone app to teach skills like stress management and goal-setting. The program aims to enhance resilience and improve quality of life for young cancer survivors by providing them with tools to cope with their unique challenges during this critical phase. Participants will engage in a series of interactive sessions designed to foster personal growth and emotional well-being.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 12-25 who have recently completed cancer treatment.
Not a fit: Patients who are not within the age range of 12-25 or who are currently undergoing active cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the mental health and quality of life for young cancer survivors.
How similar studies have performed: Previous research has shown promising results with similar resilience-building programs for young cancer patients, indicating potential for success in this approach.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Rosenberg, Abby R — Dana-Farber Cancer Inst
- Study coordinator: Rosenberg, Abby R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.